|
1
|
Kamangar F, Qiao YL, Schiller JT, Dawsey
SM, Fears T, Sun XD, Abnet CC, Zhao P, Taylor PR and Mark SD: Human
papillomavirus serology and the risk of esophageal and gastric
cancers: Results from a cohort in a high-risk region in China. Int
J Cancer. 119:579–584. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lagergren J: Oesophageal cancer in 2014:
Advances in curatively intended treatment. Nat Rev Gastroenterol
Hepatol. 12:74–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo Y, Chen Z, Zhang L, Zhou F, Shi S,
Feng X, Li B, Meng X, Ma X, Luo M, et al: Distinctive microRNA
profiles relating to patient survival in esophageal squamous cell
carcinoma. Cancer Res. 68:26–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fendler A, Jung M, Stephan C, Honey RJ,
Stewart RJ, Pace KT, Erbersdobler A, Samaan S, Jung K and Yousef
GM: miRNAs can predict prostate cancer biochemical relapse and are
involved in tumor progression. Int J Oncol. 39:1183–1192.
2011.PubMed/NCBI
|
|
7
|
Darda L, Hakami F, Morgan R, Murdoch C,
Lambert DW and Hunter KD: The role of HOXB9 and miR-196a in head
and neck squamous cell carcinoma. PLoS One. 10:e01222852015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li HL, Xie SP, Yang YL, Cheng YX, Zhang Y,
Wang J, Wang Y, Liu DL, Chen ZF, Zhou YN and Wu HY: Clinical
significance of upregulation of mir-196a-5p in gastric cancer and
enriched KEGG pathway analysis of target genes. Asian Pac J Cancer
Prev. 16:1781–1787. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fendereski M, Zia MF, Shafiee M, Safari F,
Saneie MH and Tavassoli M: MicroRNA-196a as a potential diagnostic
biomarker for esophageal squamous cell carcinoma. Cancer Invest.
35:78–84. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niinuma T, Suzuki H, Nojima M, Nosho K,
Yamamoto H, Takamaru H, Yamamoto E, Maruyama R, Nobuoka T, Miyazaki
Y, et al: Upregulation of miR-196a and HOTAIR drive malignant
character in gastrointestinal stromal tumors. Cancer Res.
72:1126–1136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu YC, Chang JT, Liao CT, Kang CJ, Huang
SF, Chen IH, Huang CC, Huang YC, Chen WH, Tsai CY, et al:
OncomiR-196 promotes an invasive phenotype in oral cancer through
the NME4-JNK-TIMP1-MMP signaling pathway. Mol Cancer. 13:2182014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu XH, Lu KH, Wang KM, Sun M, Zhang EB,
Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, et al: MicroRNA-196a
promotes non-small cell lung cancer cell proliferation and invasion
through targeting HOXA5. BMC Cancer. 12:3482012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hui AB, Shi W, Boutros PC, Miller N,
Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, et
al: Robust global micro-RNA profiling with formalin-fixed
paraffin-embedded breast cancer tissues. Lab Invest. 89:597–606.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kong X, Du Y, Wang G, Gao J, Gong Y, Li L,
Zhang Z, Zhu J, Jing Q, Qin Y and Li Z: Detection of differentially
expressed microRNAs in serum of pancreatic ductal adenocarcinoma
patients: miR-196a could be a potential marker for poor prognosis.
Dig Dis Sci. 56:602–609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu P, Xin F and Ma CF: Clinical
significance of serum miR-196a in cervical intraepithelial
neoplasia and cervical cancer. Genet Mol Res. 14:17995–18002. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jin C, Zhang Y and Li J: Upregulation of
miR-196a promotes cell proliferation by downregulating
p27kip1 in laryngeal cancer. Biol Res. 49:402016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maru DM, Singh RR, Hannah C, Albarracin
CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy
S, et al: MicroRNA-196a is a potential marker of progression during
Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in
esophagus. Am J Pathol. 174:1940–1948. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun M, Liu XH, Li JH, Yang JS, Zhang EB,
Yin DD, Liu ZL, Zhou J, Ding Y, Li SQ, et al: miR-196a is
upregulated in gastric cancer and promotes cell proliferation by
downregulating p27(kip1). Mol Cancer Ther. 11:842–852. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schimanski CC, Frerichs K, Rahman F,
Berger M, Lang H, Galle PR, Moehler M and Gockel I: High miR-196a
levels promote the oncogenic phenotype of colorectal cancer cells.
World J Gastroenterol. 15:2089–2096. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu M, Du Y, Gao J, Liu J, Kong X, Gong Y,
Li Z, Wu H and Chen H: Aberrant expression miR-196a is associated
with abnormal apoptosis, invasion, and proliferation of pancreatic
cancer cells. Pancreas. 42:1169–1181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiao Y, Ouyang C, Huang W, Tang Y, Fu W
and Cheng A: Annexin A1 can inhibit the in vitro invasive ability
of nasopharyngeal carcinoma cells possibly through Annexin
A1/S100A9/Vimentin interaction. PLoS One. 12:e01743832017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sugimoto MA, Vago JP, Teixeira MM and
Sousa LP: Annexin A1 and the resolution of inflammation: Modulation
of neutrophil recruitment, apoptosis and clearance. J Immunol Res.
2016:82392582016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boudhraa Z, Bouchon B, Viallard C, D'Incan
M and Degoul F: Annexin A1 localization and its relevance to
cancer. Clin Sci (Lond). 130:205–220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suh YE, Raulf N, Gäken J, Lawler K, Urbano
TG, Bullenkamp J, Gobeil S, Huot J, Odell E and Tavassoli M:
MicroRNA-196a promotes an oncogenic effect in head and neck cancer
cells by suppressing Annexin A1 and enhancing radioresistance. Int
J Cancer. 137:1021–1034. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang X, Wang Q, Li T, Li F and Lang J:
The negative expression of Annexin A1 in esophageal squamous cell
carcinoma is associated with poor outcome. Int J Radiat Oncol. 87
(Suppl):S288–S289. 2013. View Article : Google Scholar
|
|
27
|
Shen D, Nooraie F, Elshimali Y, Lonsberry
V, He J, Bose S, Chia D, Seligson D, Chang HR and Goodglick L:
Decreased expression of Annexin A1 is correlated with breast cancer
development and progression as determined by a tissue microarray
analysis. Hum Pathol. 37:1583–1591. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hsiang CH, Tunoda T, Whang YE, Tyson DR
and Ornstein DK: The impact of altered Annexin I protein levels on
apoptosis and signal transduction pathways in prostate cancer
cells. Prostate. 66:1413–1424. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mu D, Gao Z, Guo H, Zhou G and Sun B:
Sodium butyrate induces growth inhibition and apoptosis in human
prostate cancer DU145 cells by up-regulation of the expression of
Annexin A1. PLoS One. 8:e749222013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xia SH, Hu LP, Hu H, Ying WT, Xu X, Cai Y,
Han YL, Chen BS, Wei F, Qian XH, et al: Three isoforms of Annexin I
are preferentially expressed in normal esophageal epithelia but
down-regulated in esophageal squamous cell carcinomas. Oncogene.
21:6641–6648. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu N, Flaig MJ, Su H, Shou JZ, Roth MJ, Li
WJ, Wang C, Goldstein AM, Li G, Emmert-Buck MR and Taylor PR:
Comprehensive characterization of Annexin I alterations in
esophageal squamous cell carcinoma. Clin Cancer Res. 10:6013–6022.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Paweletz CP, Ornstein DK, Roth MJ, Bichsel
VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH,
Herring J, et al: Loss of Annexin 1 correlates with early onset of
tumorigenesis in esophageal and prostate carcinoma. Cancer Res.
60:6293–6297. 2000.PubMed/NCBI
|
|
33
|
Álvarez-Teijeiro S, Menéndez ST,
Villaronga MÁ, Pena-Alonso E, Rodrigo JP, Morgan RO, Granda-Díaz R,
Salom C, Fernandez MP and García-Pedrero JM: Annexin A1
down-regulation in head and neck squamous cell carcinoma is
mediated via transcriptional control with direct involvement of
miR-196a/b. Sci Rep. 7:67902017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu X, Li P, Zhang ST, You H, Jia JD and
Yu ZL: COX-2 mRNA expression in esophageal squamous cell carcinoma
(ESCC) and effect by NSAID. Dis Esophagus. 21:9–14. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shao Y, Li P, Zhu ST, Yue JP, Ji XJ, He Z,
Ma D, Wang L, Wang YJ, Zong Y, et al: Cyclooxygenase-2, a potential
therapeutic target, is regulated by miR-101 in esophageal squamous
cell carcinoma. PLoS One. 10:e01406422015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shao Y, Li P, Zhu ST, Yue JP, Ji XJ, Ma D,
Wang L, Wang YJ, Zong Y, Wu YD and Zhang ST: miR-26a and miR-144
inhibit proliferation and metastasis of esophageal squamous cell
cancer by inhibiting cyclooxygenase-2. Oncotarget. 7:15173–15186.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao Y, Chen Y, Xu D, Wang J and Yu G:
Differential expression of ANXA1 in benign human gastrointestinal
tissues and cancers. BMC Cancer. 14:5202014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hannon R, Croxtall JD, Getting SJ,
Roviezzo F, Yona S, Paul-Clark MJ, Gavins FN, Perretti M, Morris
JF, Buckingham JC and Flower RJ: Aberrant inflammation and
resistance to glucocorticoids in Annexin 1−/− mouse.
FASEB J. 17:253–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Croxtall JD, Newman SP, Choudhury Q and
Flower RJ: The concerted regulation of cPLA2, COX2, and lipocortin
1 expression by IL-1beta in A549 cells. Biochem Biophys Res Commun.
220:491–495. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dohadwala M, Yang SC, Luo J, Sharma S,
Batra RK, Huang M, Lin Y, Goodglick L, Krysan K, Fishbein MC, et
al: Cyclooxygenase-2-dependent regulation of E-cadherin:
Prostaglandin E(2) induces transcriptional repressors ZEB1 and
snail in non-small cell lung cancer. Cancer Res. 66:5338–5345.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen Z, Liu M, Liu X, Huang S, Li L, Song
B, Li H, Ren Q, Hu Z, Zhou Y and Qiao L: COX-2 regulates E-cadherin
expression through the NF-κB/Snail signaling pathway in gastric
cancer. Int J Mol Med. 32:93–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Y, Ma J, Guo Q, Duan F, Tang F, Zheng
P, Zhao Z and Lu G: Overexpression of MMP-2 and MMP-9 in esophageal
squamous cell carcinoma. Dis Esophagus. 22:664–667. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
McGuire JK, Li Q and Parks WC: Matrilysin
(matrix metalloproteinase-7) mediates E-cadherin ectodomain
shedding in injured lung epithelium. Am J Pathol. 162:1831–1843.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fujii R, Imanishi Y, Shibata K, Sakai N,
Sakamoto K, Shigetomi S, Habu N, Otsuka K, Sato Y, Watanabe Y, et
al: Restoration of E-cadherin expression by selective Cox-2
inhibition and the clinical relevance of the
epithelial-to-mesenchymal transition in head and neck squamous cell
carcinoma. J Exp Clin Cancer Res. 33:402014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kurihara Y, Hatori M, Ando Y, Ito D,
Toyoshima T, Tanaka M and Shintani S: Inhibition of
cyclooxygenase-2 suppresses the invasiveness of oral squamous cell
carcinoma cell lines via down-regulation of matrix
metalloproteinase-2 production and activation. Clin Exp Metastasis.
26:425–432. 2009. View Article : Google Scholar : PubMed/NCBI
|
